or Try an Advanced Search...

    Technical Analysis for TCBP - TC BioPharm (Holdings) plc

    Grade Last Price % Change Price Change
    F 1.12 -2.61% -0.03
    TCBP closed down 2.61 percent on Wednesday, May 15, 2024, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TCBP trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    BB Squeeze Ended Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction -2.61%
    Calm After Storm Range Contraction -2.61%
    Narrow Range Bar Range Contraction -2.61%
    Lower Bollinger Band Walk Weakness -2.61%
    Wide Bands Range Expansion -2.61%
    Older End-of-Day Signals for TCBP ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 13 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    Down 3% about 14 hours ago
    Up 2% about 16 hours ago
    Up 1% about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TCBP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Solid Tumors Immune System Immunotherapy Cancer Treatment Cancer Immunotherapy Cell Therapy Acute Myeloid Leukemia Cell Biology Treatment Of Acute Myeloid Leukemia T Cells Immunotherapy Products

    Is TCBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 TCBP Announces Launch of Compassionate Use Program for TCB008
    May 6 TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
    May 6 TC Biopharm executes second LOI to buy CAR-T therapies, shares up
    May 6 TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
    Apr 5 Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket
    Apr 4 TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics
    Apr 4 TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
    Apr 2 TCBP to raise treatment capacity with expanded manufacturing process
    Apr 2 TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
    Mar 19 TCBP Adjourns General Meeting Until a Later Date
    See more TCBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.0
    52 Week Low 0.8501
    Average Volume 6,006,714
    200-Day Moving Average 5.19
    50-Day Moving Average 1.47
    20-Day Moving Average 1.38
    10-Day Moving Average 1.26
    Average True Range 0.23
    RSI (14) 35.48
    ADX 38.29
    +DI 41.40
    -DI 17.65
    Chandelier Exit (Long, 3 ATRs) 2.30
    Chandelier Exit (Short, 3 ATRs) 1.76
    Upper Bollinger Bands 1.70
    Lower Bollinger Band 1.06
    Percent B (%b) 0.09
    BandWidth 46.13
    MACD Line -0.10
    MACD Signal Line -0.07
    MACD Histogram -0.0344
    Fundamentals Value
    Market Cap 757.68 Thousand
    Num Shares 677 Thousand
    EPS -71.42
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 0.36
    Price-to-Book 0.29
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.23
    Resistance 3 (R3) 1.23 1.21 1.21
    Resistance 2 (R2) 1.21 1.18 1.20 1.20
    Resistance 1 (R1) 1.16 1.16 1.15 1.16 1.20
    Pivot Point 1.14 1.14 1.13 1.13 1.14
    Support 1 (S1) 1.09 1.11 1.08 1.09 1.04
    Support 2 (S2) 1.07 1.09 1.06 1.04
    Support 3 (S3) 1.02 1.07 1.03
    Support 4 (S4) 1.02